Investment bank Goldman Sachs has published figures indicating that growth in emerging markets is not what it used to be. A lot of Medical Technologies companies are trying to compensate for sluggish growth in developed markets, such as the US and Western Europe by expanding into BRIC markets (Brazil, Russia, India, China). Growth indices generated by Goldman Sachs, however, indicate that growth will stay flat at 7.9 percent for 2012.
Read the full story here
Tags:
Follow Life Sciences networks on LinkedIn
GlobalScots, Nexxus, Interface, Centre for Health Science
Follow Life Sciences Scotland on Twitter
Susan Sewell posted events
Carolyn McTaggart posted an event
© 2012 Created by Siobhan McDermit.
Powered by